Movement Alert｜WuXi Biologics Falls 3.15% in Regular Trading, Buyback Rally Fades as CXO Sector Sells Off Broadly

Market Focus

May 28

On May 28, WuXi Biologics fell 3.15% in regular trading, trading at HK$32.58/share, with trading volume of HK$89.4 million. The decline marks the second consecutive session of losses following the stock's sharp rally on May 26, when it surged as much as 7% on the announcement of a US$400 million share buyback plan.

The initial buyback euphoria has faded amid multiple headwinds. Market participants have flagged the contradiction between the company's repurchase and major shareholder Biologics Holdings' disposal of 150 million shares at HK$38.52 per share just 11 days prior, reducing its stake below the major shareholder threshold. Additionally, the upcoming removal of CXO companies from the Hang Seng Hong Kong-listed Innovative Drug index effective June 30 is expected to trigger passive selling from tracking ETFs, with WuXi Biologics previously holding approximately 9.8% index weight.

The broader CXO sector is under pressure, with WUXI APPTEC down 3.05%, GENSCRIPT BIO down 3.23%, and WUXI XDC down 3.49%. The CSI CXO Index trades at 26.30x TTM PE, sitting at only the 16.19th percentile since inception.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1116655233"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1116655233\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1116655233?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-28 09:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1116655233","market":"us","top_or_hot":-1,"title":"Movement Alert｜WuXi Biologics Falls 3.15% in Regular Trading, Buyback Rally Fades as CXO Sector Sells Off Broadly","media":"Market Focus","content":"<p><p>On May 28, WuXi Biologics fell 3.15% in regular trading, trading at HK$32.58/share, with trading volume of HK$89.4 million. The decline marks the second consecutive session of losses following the stock's sharp rally on May 26, when it surged as much as 7% on the announcement of a US$400 million share buyback plan.</p><p>The initial buyback euphoria has faded amid multiple headwinds. Market participants have flagged the contradiction between the company's repurchase and major shareholder Biologics Holdings' disposal of 150 million shares at HK$38.52 per share just 11 days prior, reducing its stake below the major shareholder threshold. Additionally, the upcoming removal of CXO companies from the Hang Seng Hong Kong-listed Innovative Drug index effective June 30 is expected to trigger passive selling from tracking ETFs, with WuXi Biologics previously holding approximately 9.8% index weight.</p><p>The broader CXO sector is under pressure, with WUXI APPTEC down 3.05%, GENSCRIPT BIO down 3.23%, and WUXI XDC down 3.49%. The CSI CXO Index trades at 26.30x TTM PE, sitting at only the 16.19th percentile since inception.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜WuXi Biologics Falls 3.15% in Regular Trading, Buyback Rally Fades as CXO Sector Sells Off Broadly</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜WuXi Biologics Falls 3.15% in Regular Trading, Buyback Rally Fades as CXO Sector Sells Off Broadly\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-05-28 09:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On May 28, WuXi Biologics fell 3.15% in regular trading, trading at HK$32.58/share, with trading volume of HK$89.4 million. The decline marks the second consecutive session of losses following the stock's sharp rally on May 26, when it surged as much as 7% on the announcement of a US$400 million share buyback plan.</p><p>The initial buyback euphoria has faded amid multiple headwinds. Market participants have flagged the contradiction between the company's repurchase and major shareholder Biologics Holdings' disposal of 150 million shares at HK$38.52 per share just 11 days prior, reducing its stake below the major shareholder threshold. Additionally, the upcoming removal of CXO companies from the Hang Seng Hong Kong-listed Innovative Drug index effective June 30 is expected to trigger passive selling from tracking ETFs, with WuXi Biologics previously holding approximately 9.8% index weight.</p><p>The broader CXO sector is under pressure, with WUXI APPTEC down 3.05%, GENSCRIPT BIO down 3.23%, and WUXI XDC down 3.49%. The CSI CXO Index trades at 26.30x TTM PE, sitting at only the 16.19th percentile since inception.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02269","symbol_name":"药明生物","start_time":0,"source_url":"","article_id":"1116655233","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1116655233","pubTimestamp":1779933444,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On May 28, WuXi Biologics fell 3.15% in regular trading, trading at HK$32.58/share, with trading volume of HK$89.4 million. The decline marks the second consecutive session of losses following the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02269":"药明生物"},"translate_title":"动向提示|药明生物常规交易跌3.15%CXO板块广泛抛售回购涨势消退","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02269":1},"content_text":"On May 28, WuXi Biologics fell 3.15% in regular trading, trading at HK$32.58/share, with trading volume of HK$89.4 million. The decline marks the second consecutive session of losses following the stock's sharp rally on May 26, when it surged as much as 7% on the announcement of a US$400 million share buyback plan.The initial buyback euphoria has faded amid multiple headwinds. Market participants have flagged the contradiction between the company's repurchase and major shareholder Biologics Holdings' disposal of 150 million shares at HK$38.52 per share just 11 days prior, reducing its stake below the major shareholder threshold. Additionally, the upcoming removal of CXO companies from the Hang Seng Hong Kong-listed Innovative Drug index effective June 30 is expected to trigger passive selling from tracking ETFs, with WuXi Biologics previously holding approximately 9.8% index weight.The broader CXO sector is under pressure, with WUXI APPTEC down 3.05%, GENSCRIPT BIO down 3.23%, and WUXI XDC down 3.49%. The CSI CXO Index trades at 26.30x TTM PE, sitting at only the 16.19th percentile since inception.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}